Cannabidiol in Neurology: Current Insights and Translational Perspectives

Area of Science:

• Neuroscience
• Pharmacology
• Cannabis Research

Background:

• Cannabidiol (CBD) from Cannabis sativa is extensively studied for therapeutic properties.
• Unlike THC, CBD lacks intoxicating effects, making it suitable for neurological applications.
• Preclinical and clinical studies highlight CBD's antioxidant, analgesic, anti-inflammatory, and neuroprotective actions.

Purpose of the Study:

• To review preclinical and clinical research on CBD's efficacy in neurological conditions.
• To evaluate the therapeutic potential of CBD for various neurological disorders.
• To address safety concerns and drug-drug interactions associated with CBD use.

Main Methods:

• Systematic review of preclinical studies.
• Analysis of clinical trial data.
• Assessment of reported adverse effects and drug interactions.

Main Results:

• CBD demonstrates potential benefits for epilepsy (Epidiolex), multiple sclerosis spasticity (Sativex), and suggests promise for chronic pain, Alzheimer's, Parkinson's, and stroke.
• Common side effects like somnolence and diarrhea are generally mild.
• Significant drug-drug interactions involving CBD have been reported.

Conclusions:

• CBD is a promising therapeutic agent for neurological disorders due to its non-psychoactive profile and beneficial properties.
• Further research is warranted to fully understand CBD's efficacy and manage potential risks, particularly drug interactions.
• CBD's favorable safety profile, coupled with its therapeutic potential, supports its continued investigation for neurological conditions.